Saarum Sciences

Hyderabad, India Founded: 2012 • Age: 14 yrs
Biotechnology services focused on drug discovery platforms and research collaborations.

About Saarum Sciences

Saarum Sciences is a Healthcare company based in Hyderabad (India) founded in 2012. Biotechnology services focused on drug discovery platforms and research collaborations. Its Indian entity Saarum Sciences Private Limited reported revenue of β‚Ή1.9 Lakh. Saarum Sciences offers products and services including OncoPrime and Biobanking Services. Its focus areas include Life Sciences, Research Services, Biobanking and Biotechnology.

Company details

Saarum Sciences is identified as a provider of phenotypic drug discovery platforms, where OncoPrime is utilized to accelerate research using primary cells from tumor tissues. Access to patient-derived samples is facilitated through biobanking services, and custom RD projects are offered for target validation in a multi-omics context. Partnerships are established with biotech and pharma clients to enhance drug development processes, emphasizing physiologically relevant disease models. The companys infrastructure supports collaborations in academia and industry for efficient drug repositioning efforts.

  • Headquarters Hyderabad, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website saarum.co.in
  • Social LinkedIn X Facebook
  • Legal Name Saarum Sciences Pvt Ltd
  • Date of Incorporation 12 Feb, 2011
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹1.9 Lakh

    FY 2024 · -49% YoY

  • Net Loss
    -₹13,649

    FY 2024 · -7% margin

  • EBITDA
    ₹1.2 Lakh

    FY 2024 · 62% margin

Products & Services of Saarum Sciences

Saarum Sciences offers a comprehensive portfolio of products and services, including OncoPrime and Biobanking Services.

OncoPrime
Drug Discovery Platform

A phenotypic drug discovery platform is utilized for characterizing disease phenotypes and studying drug responses in native states.

Biobanking Services
Biobanking

Access to patient-derived samples is provided through biobanking services to support research in biotechnology and pharma.

Board of directors of Saarum Sciences Private Limited (Saarum Sciences)

Saarum Sciences Private Limited is the primary company behind Saarum Sciences. The board of Saarum Sciences Private Limited currently have 2 directors; the longest-serving is Sreevatsa Natarajan Gopinath, appointed in 2011. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sreevatsa Natarajan Gopinath
DIN 03250178
Director12 Feb 201115 yrs 9 moSaarum Sciences Private Limited
Jugnu Jain
DIN 03518645
Director11 Oct 201214 yrs 1 moSaarum Sciences Private Limited

Financials of Saarum Sciences

Figures of Saarum Sciences Private Limited, the primary company behind Saarum Sciences, for FY 2024. Revenue was ₹1.9 Lakh (-49% year on year). Net loss was -₹13,649 (-7% margin). EBITDA was ₹1.2 Lakh (62% margin). Revenue has grown at a compounded annual rate of -61% over three years and -44% over five years.

  • ₹1.9 LakhRevenue · FY 2024 · -49% YoY
  • -₹13,649Net loss · -7% margin
  • ₹1.2 LakhEBITDA · 62% margin
  • ₹1 LakhPaid-up capital
  • -61%Revenue CAGR, 3 years
  • -44%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Saarum Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for Saarum Sciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Saarum Sciences

Saarum Sciences was founded in 2012.

Saarum Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind Saarum Sciences, Saarum Sciences Private Limited, reported revenue of β‚Ή1.9 Lakh for FY 2024, down 49% year on year.

Saarum Sciences is identified as a provider of phenotypic drug discovery platforms, where OncoPrime is utilized to accelerate research using primary cells from tumor tissues. Access to patient-derived samples is facilitated through biobanking services, and custom RD projects are offered for target validation in a multi-omics context. Partnerships are established with biotech and pharma clients to enhance drug development processes, emphasizing physiologically relevant disease models. The companys infrastructure supports collaborations in academia and industry for efficient drug repositioning efforts.

Saarum Sciences offers OncoPrime and Biobanking Services.

Saarum Sciences operates through Saarum Sciences Private Limited.

The legal entities of Saarum Sciences currently have 2 directors, including Sreevatsa Natarajan Gopinath, Jugnu Jain.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available